Shukra Pharmaceuticals Balance Sheet Annual

BSE: 524632 | NSE: SHUKRAPHAR | ISIN: INE551C01044 | Sector: Biotechnology & Drugs

53.94 +0.02 (0.04%)Updated : 11 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	117.41	86.77	77.84	74.97
Accumulated Depreciation Total	-27.83	-24.39	-	-
Other Liabilities Total	0.11	0.13	0.11	0.11
Accrued Expenses	1.00	1.05	-	-
Long Term Debt	3.19	3.11	2.66	3.77
Common Stock Total	43.79	43.79	10.94	3.91
Other Equity Total	0.00	0.00	46.69	21.38
Other Current Assets Total	6.38	1.36	17.10	13.22
Prepaid Expenses	0.03	0.01	-	-
Total Assets	117.41	86.77	77.84	74.97
Current Portof LT Debt/ Capital Leases	1.83	1.06	0.50	1.31
Additional Paid- In Capital	4.74	4.74	0.00	-
Cash	5.92	12.12	9.98	3.97
Total Equity	89.83	62.84	57.64	25.30
Long Term Investments	0.03	-	-	-
Retained Earnings( Accumulated Deficit)	41.30	14.31	-	-
Total Common Shares Outstanding	43.79	43.79	43.79	6.26
Property/ Plant/ Equipment Total- Gross	61.46	45.73	-	-
Tangible Book Valueper Share Common Eq	2.05	1.44	1.32	4.04
Total Liabilities	27.58	23.93	20.20	49.67
Total Debt	5.02	4.18	3.15	5.08
Cashand Short Term Investments	5.92	12.12	9.98	3.97
Total Receivables Net	55.80	37.80	26.83	32.72
Notes Payable/ Short Term Debt	0.00	0.00	0.00	0.00
Deferred Income Tax	1.19	3.41	3.27	3.29
Accounts Receivable- Trade Net	52.43	27.44	24.51	30.19
Property/ Plant/ Equipment Total- Net	33.63	21.34	21.60	21.89
Total Current Liabilities	23.08	17.28	14.15	42.51
Total Inventory	15.62	14.14	2.31	3.16
Accounts Payable	10.07	9.22	7.22	34.25
Other Currentliabilities Total	10.19	5.96	6.43	6.94
Total Long Term Debt	3.19	3.11	2.66	3.77
period Length	0.00	0.00	0.00	0.00
Total Current Assets	83.75	65.43	56.23	53.07